Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial

Table 1 Measures and assessment points used in the study

Variable	Measure	Assessment method	T0 Baseline	T1 Post treatment	T2 3 months	T3 6 months
SUD diagnosis	IDCL [31]	interview	x	x	x	x
PTSD diagnosis	CAPS [33]	interview	x	x	x	x
PTSD symptoms	CAPS [33]	interview	x	x	x	x
Early traumatic experiences	CTQ [46]	self-report	x	x	x	x
Substance use	AUDIT [37]/DUDIT [40] TLFB [41]	interview	x	x	x	x
Addiction-related problems	ASI-Lite [42]	interview	x	x	x	x
Dissociative symptoms	DES [25]	self-report	x	x	x	x
Depressive symptoms	BDI-II [43]	self-report	x	x	x	x
Emotion dysregulation	DERS [44]	self-report	x	x	x	x
Quality of life	SF-12 [45]	self-report	x	x	x	x
Safety	SAE Report Form	self-report	----------------		x	x

Notes. IDCL International Diagnostic Checklists. CAPS Clinician-Administered PTSD Scale. CTQ Childhood Trauma Questionnaire. AUDIT Alcohol Use Disorders Identification Test. DUDIT Drug Use Disorders Identification Test. TLFB Timeline Follow Back. ASI-Lite Addiction Severity Index-Lite. DES Dissociative Experience Scale. BDI-II Beck Depression Inventory-II. DERS Difficulties in Emotion Regulation Scale. SF-12 Short-Form 12-Item Health Survey. SAE Serious Adverse Event

ISSN: 1471-244X